CIBC Bancorp USA’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$278M Sell
1,048,677
-303,947
-22% -$80.2M 0.35% 63
2026
Q2
$343M Sell
1,352,624
-320,535
-19% -$74.7M 0.42% 53
2026
Q1
$409M Buy
+1,673,159
New +$390M 0.55% 35
2025
Q3
$119M Buy
+642,781
New +$110M 0.65% 25

Other funds holding JNJ

CIBC Bancorp USA's JNJ Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Johnson & Johnson (JNJ) stake by 22% in Q3 2026, selling an estimated $80.2M and leaving 1,048,677 shares worth $278M. The position accounts for 0.35% of the portfolio, ranked #63.

CIBC Bancorp USA first reported a position in JNJ in Q3 2025 and has held it in 4 quarters since. The position peaked at $409M in Q1 2026. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • CIBC Bancorp USA held 1,048,677 shares of Johnson & Johnson worth $278M as of Q3 2026.
  • CIBC Bancorp USA sold 303,947 Johnson & Johnson shares in Q3 2026, an estimated $80.2M.
  • Johnson & Johnson made up 0.35% of CIBC Bancorp USA's portfolio in Q3 2026, its #63 holding.
  • CIBC Bancorp USA first reported a position in Johnson & Johnson in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Johnson & Johnson position peaked at $409M in Q1 2026.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.